Sebaceous carcinoma of the vulva: a clinical case and a literature review
Open Access
- 28 August 2026
- journal article
- Published by Russian Society of Clinical Oncology in Malignant tumours
- Vol. 16 (2) , 97-107
Abstract
Background. Vulvar cancer (VC) is a rare malignancy in women, accounting for no more than 4 % of all cancers. Sebaceous histologic subtypes of VC are exceptionally uncommon. We summarize our own experience and that of other authors regarding presentation, diagnosis, and management. Objective. To present a clinical case of vulvar sebaceous carcinoma and synthesize the available literature to clarify the clinicopathologic features, diagnostics, treatment, and prognosis of this malignancy. Materials and Methods. We described a clinical case of vulvar sebaceous carcinoma treated at our center. In addition, we conducted a systematic literature review (PubMed, MEDLINE, Cochrane Library, eLibrary.ru; 1970–2025; keywords “sebaceous carcinoma”, “vulvar cancer”) of published cases. Results. Immunohistochemistry confirmed sebaceous carcinoma (EMA+, pan-CK+, S100 / Melan-A–); stage IB (pT1bN0M0). A hemivulvectomy achieved a clear margin ≥ 10 mm; no adjuvant therapy was given; at 21‑month follow-up there was no recurrence. The literature review of 16 cases showed that the vast majority of patients (~ 80 %) underwent surgical treatment; inguinal lymph-node metastases were reported in ~ 20 %, and distant metastases in < 10 %. In isolated reports, adjuvant radiotherapy and immunotherapy (PD-1 inhibitors) were used for advanced disease. Conclusion . Vulvar sebaceous carcinoma is exceedingly rare and insufficiently studied, requiring an individualized, multidisciplinary approach. In localized stages, radical surgical excision provides a favorable prognosis. Regional lymph-node assessment is preferably performed via sentinel lymph-node biopsy, and all patients should undergo immunohistochemical evaluation of the mismatch-repair (MMR) system to exclude Muir — Torre syndrome and to determine eligibility for targeted and / or immunotherapy.Keywords
This publication has 32 references indexed in Scilit:
- Sebaceous carcinoma of the eyelid in a patient with Muir-Torre syndrome treated with pembrolizumab: A case reportCurrent Problems in Cancer: Case Reports, 2022
- Sebaceous carcinoma of the vulva treated with sentinel lymph node biopsy: a case report and literature reviewInternational Cancer Conference Journal, 2021
- Sebaceous carcinoma of the vulva: A case report and review of the literatureGynecologic Oncology Reports, 2016
- Muir-Torre syndrome (MTS): An update and approach to diagnosis and managementJournal of the American Academy of Dermatology, 2016
- Noninvasive and Curative Radiation Therapy for Sebaceous Carcinoma of the EyelidInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Epidemiology of sebaceous carcinoma of the head and neck: Implications for lymph node managementHead & Neck, 2012
- A retrospective review of 1349 cases of sebaceous carcinomaCancer, 2008
- Sebaceous Carcinoma of the Vulva: A Case Report and Review of the LiteratureGynecologic Oncology, 1996
- Sebaceous Carcinoma Arising From Bowen's Disease of the VulvaArchives of Dermatology, 1986
- Cutaneous sebaceous neoplasmsCancer, 1974